Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02397720
What this trial is testing

Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+6 more
M.D. Anderson Cancer Center 150
Not applicableUnknownNCT05360420
What this trial is testing

Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure

Who this might be right for
Liver CancerLiver Cirrhosis
Tianjin Third Central Hospital 6,730
Very early researchActive Not RecruitingNCT05386576
What this trial is testing

Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 12
Not applicableUnknownNCT05297162
What this trial is testing

PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial

Who this might be right for
Prostate Cancer
Istituto Clinico Humanitas 128
Not applicableUnknownNCT05518591
What this trial is testing

COMpassion FOcused Therapy and Breathing Pattern REtraining After Cancer Recurrence

Who this might be right for
Psychological DistressCancer Recurrence
University College Dublin 160
Not applicableLooking for participantsNCT07481890
What this trial is testing

Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients.

Who this might be right for
CancerPsychological Distress
Lega Cancro Ticino 46
Testing effectiveness (Phase 2)Study completedNCT00082797
What this trial is testing

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 36
Not applicableWithdrawnNCT01233479
What this trial is testing

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Testing effectiveness (Phase 2)UnknownNCT04614493
What this trial is testing

Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.

Who this might be right for
Initial Radiological Diagnosis Eligible for Tumor ResectionInitial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)Study completedNCT03417284
What this trial is testing

Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation

Who this might be right for
Plasma Cell Myeloma
M.D. Anderson Cancer Center 62
Very early researchLooking for participantsNCT07468708
What this trial is testing

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Who this might be right for
Healthy AdultProstate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd. 10
Testing effectiveness (Phase 2)UnknownNCT01124240
What this trial is testing

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene

Who this might be right for
Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
Northern Sydney and Central Coast Area Health Service 48
Large-scale testing (Phase 3)Study completedNCT00075725
What this trial is testing

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 3,154
Not applicableLooking for participantsNCT05739968
What this trial is testing

Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients

Who this might be right for
Bladder CancerQuality of Life
National Taiwan University Hospital 120
Early research (Phase 1)Ended earlyNCT02510950
What this trial is testing

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IV
Washington University School of Medicine 1
Large-scale testing (Phase 3)Active Not RecruitingNCT05936658
What this trial is testing

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

Who this might be right for
High Risk Prostate Carcinoma
FutureChem 138
Testing effectiveness (Phase 2)Study completedNCT01611116
What this trial is testing

Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloblastic Leukemia
Goethe University 33
Not applicableStudy completedNCT02553447
What this trial is testing

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaUntreated Chronic Lymphocytic Leukemia+1 more
University of Nebraska 197
Testing effectiveness (Phase 2)Study completedNCT00028678
What this trial is testing

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 45
Testing effectiveness (Phase 2)UnknownNCT04824924
What this trial is testing

Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Shanghai Jiao Tong University School of Medicine 100
Next Page